Definium Therapeutics (DFTX) had the highest return between January 1, 2020 and April 30, 2020 by a mid-cap US stock or mid-cap US stock, returning 703.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Definium Therapeutics (DFTX) | 1/1/2020 - 4/30/2020 | 703.57% |
Arcus Biosciences (RCUS) | 1/1/2020 - 4/30/2020 | 161.49% |
Aura Minerals Inc Common Shares (AUGO) | 1/1/2020 - 4/30/2020 | 126.17% |
Acm Research (ACMR) | 1/1/2020 - 4/30/2020 | 113.19% |
Kiniksa Pharmaceuticals (KNSA) | 1/1/2020 - 4/30/2020 | 79.57% |
Schrodinger (SDGR) | 1/1/2020 - 4/30/2020 | 78.46% |
Enphase Energy (ENPH) | 1/1/2020 - 4/30/2020 | 77.59% |
iRhythm Technologies (IRTC) | 1/1/2020 - 4/30/2020 | 53.81% |
Bill Com (BILL) | 1/1/2020 - 4/30/2020 | 53.52% |
Zai Lab (ZLAB) | 1/1/2020 - 4/30/2020 | 50.23% |
Virtu Financial (VIRT) | 1/1/2020 - 4/30/2020 | 47.69% |
Youdao (DAO) | 1/1/2020 - 4/30/2020 | 47.51% |
Chewy (CHWY) | 1/1/2020 - 4/30/2020 | 47.48% |
Calix (CALX) | 1/1/2020 - 4/30/2020 | 43.75% |
Cytokinetics (CYTK) | 1/1/2020 - 4/30/2020 | 42.01% |
Bilibili (BILI) | 1/1/2020 - 4/30/2020 | 40.68% |
Five9 (FIVN) | 1/1/2020 - 4/30/2020 | 40.2% |
Wingstop (WING) | 1/1/2020 - 4/30/2020 | 36.18% |
Skeena Resources (SKE) | 1/1/2020 - 4/30/2020 | 35.85% |
Ringcentral (RNG) | 1/1/2020 - 4/30/2020 | 34.43% |
AtriCure (ATRC) | 1/1/2020 - 4/30/2020 | 31.7% |
PLDT Inc ADR (PHI) | 1/1/2020 - 4/30/2020 | 30.48% |
Merit Medical Systems (MMSI) | 1/1/2020 - 4/30/2020 | 29.96% |
Arcutis Biotherapeutics (ARQT) | 1/1/2020 - 4/30/2020 | 28.88% |
Mercury Systems (MRCY) | 1/1/2020 - 4/30/2020 | 27.88% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.